Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids

Enrofloxacin-loaded solid lipid nanoparticles (SLN) were prepared using fatty acids (tetradecanoic acid, palmitic acid, stearic acid) as lipid matrix by hot homogenization and ultrasonication method. The effect of fatty acids on the characteristics and pharmacokinetics of the SLN were investigated. The results showed that the encapsulation efficiency and loading capacity of nanoparticles varied with fatty acids in the order of stearic acid>palmitic acid>tetradecanoic acid. Furthermore, stearic acid-SLN had larger particle size, bigger polydispersity index (PDI) and higher zeta potential compared with the other two fatty acid formulated SLN. The SLN showed sustained releases in vitro and the released enrofloxacin had the same antibacterial activity as that of the native enrofloxacin. Although in vitro release exhibited similar patterns, within 24 h the releasing rates of the three formulations were significantly different (tetradecanoic acid-SLN>palmitic acid-SLN>stearic acid-SLN). Pharmacokinetic study after a single dose of intramuscular administration to mice demonstrated that tetradecanoic acid-SLN, palmitic acid-SLN, and stearic acid-SLN increased the bioavailability by 6.79, 3.56 and 2.39 folds, and extended the mean residence time (MRT) of the drug from 10.60 h to 180.36, 46.26 and 19.09 h, respectively. These results suggest that the enrofloxacin-fatty acid SLN are promising formulations for sustained release while fatty acids had significant influences on the characteristics and performances of the SLN.     

Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) coated with human serum albumin (HSA) were fabricated for formulating nevirapine (NVP). Here, NLCs contained low-melting-point oleic acid (OA) in the internal lipid phase. The results revealed that the two nanoparticles were uniformly distributed with the average diameter ranging from 145 to 180 nm. The surface HSA neutralized the positive charge of dimethyldioctadecyl ammonium bromide (DODAB) on SLNs and NLCs and reduced their zeta potential. In a fixed ratio of solid lipids, SLNs entrapped more NVP than NLCs. The incorporation of OA also reduced the thermal resistance of NLCs and accelerated the release of NVP from the nanocarriers. When incubated with DODAB-stabilized SLNs, the viability of human brain-microvascular endothelial cells (HBMECs) reduced. However, the surface HSA increased the viability of HBMECs about 10% when the concentration of SLNs was higher than 0.8 mg/mL. HSA-grafted SLNs and NLCs can be effective formulations in the delivery of NVP for viral therapy.     

Antitumor activity and pharmacokinetics of podophyllotoxin incorporated into solid lipid nanoparticles

To evaluate the antitumor activity and pharmacokinetics of podophyllotoxin (PPT) incorporated into solid lipid nanoparticles (SLN), Kunming mice inoculated with flesh tumor were used as animal model. The mice received a single daily intraperitoneal injection of PPT in 20% ethanol (5 mg/kg) and PPT-SLN (5 mg/kg in PPT) for 3 weeks. Gross tumor volumes, body weight and clinical observations were recorded daily. The mice were sacrificed for 24 h after the last administration, and the tumor inhibition rate was calculated with the tumor weight. For the pharmacokinetics research, the mice were treated with intraperitoneal injection of PPT (10 mg/kg) and PPT-SLN (10 mg/kg in PPT). Blood samples were collected at different time to determine the PPT concentration in plasma by HPLC. Blood drug level-time curve was made and pharmacokinetic parameters were calculated. As a result of drug administration, the tumor volume and weight of the mice injected with PPT-SLN were significantly restrained compared with mice treated with PPT or negative control. The tumor inhibition rate of 58.13% showed a significant antitumor activity of PPT-SLN. At the same time, the increased weight gain of the mice injected with PPT-SLN suggested a reduced toxicity of PPT in SLN. Pharmacokinetics study displayed a higher blood concentration, a prolonged circulation time, and an increased bioavailability of PPT-SLN compared with those of PPT. Our results demonstrated that PPT-SLN could optimize pharmacokinetics, enhance antitumor activity and attenuate toxicity, so it has a promising prospect for the application in anti-tumor treatment. Supported by the National Natural Science Foundation of China (Grant No. 50673078), the Innovation Program of Shanghai Municipal Education Commission (Grant No. 08ZZ21) and the Shanghai Key Fundamental Project (Grant No. 07DZ19603)     

Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles

Most proteins are hydrophilic and poorly encapsulated into the hydrophobic matrix of solid lipid nanoparticles (SLN). To solve this problem, poly (lactic-co-glycolic acid) (PLGA) was utilized as a lipophilic polymeric emulsifier to prepare hydrophilic protein-loaded SLN by w/o/w double emulsion and solvent evaporation techniques. Hydrogenated castor oil (HCO) was used as a lipid matrix and bovine serum albumin (BSA), lysozyme and insulin were used as model proteins to investigate the effect of PLGA on the formulation of the SLN. The results showed that PLGA was essential for the primary w/o emulsification. In addition, the stability of the w/o emulsion, the encapsulation efficiency and loading capacity of the nanoparticles were enhanced with the increase of PLGA concentration. Furthermore, increasing PLGA concentration decreased zeta potential significantly but had no influence on particle size of the SLN. In vitro release study showed that PLGA significantly affected the initial burst release, i.e. the higher the content of PLGA, the lower the burst release. The released proteins maintained their integrity and bioactivity as confirmed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and biological assay. These results demonstrated that PLGA was an effective emulsifier for the preparation of hydrophilic protein-loaded SLN.     

Alternative sample preparation prior to two-dimensional electrophoresis protein analysis on solid lipid nanoparticles

The proteins adsorbing onto the surface of intravenously injected drug carriers are regarded as a key factor determining the organ distribution. Depending on the particle surface properties, certain proteins will be preferentially adsorbed, leading to the adherence of the particle to cells with the appropriate receptor. Therefore, the knowledge of the protein adsorption pattern and the correlation to in vivo behavior opens the perspective for the development of intravenous colloidal carriers for drug targeting. After incubation in plasma, the adsorbed proteins were analyzed using two-dimensional polyacrylamide gel electrophoresesis (2-D PAGE, 2-DE). The purpose of the present study was to develop an alternative separation method to separate solid lipid nanoparticles (SLN) carriers from plasma by gel filtration prior to 2-D PAGE. Via the specific absorption coefficients and a two-equation system, elution fractions were identified being practically plasma-free. This allows protein analysis on SLN which are typically in density too close to the density value of water to be separated by the standard centrifugation method. The SLN used for establishing the gel filtration were prepared in a way that they had a sufficiently low density to be additionally separated by centrifugation. The adsorption patterns obtained after separation with both methods were qualitatively and quantitatively identical, showing the suitability of the gel filtration.     

Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system

In this study, water-in-oil (W/O) miniemulsion was used as nanoreactor to prepare solid lipid nanoparticles (SLN) by solvent diffusion method. n-Hexane, Tween 80 and Span 80 were used as the oil phase and surfactant combination for preparation of W/O miniemulsion, respectively. The stable miniemulsion with the particle size of 27.1 ± 7.6 nm was obtained when the composition of water/Tween 80/Span 80/n-hexane was 1 ml/18 mg/200 mg/10 ml. Clobetasol propionate (CP) was used as a model drug. The physicochemical properties of the SLN, such as particle size, zeta potential, surface morphology, drug entrapment efficiency, drug loading capacity and in vitro drug release behaviors were investigated, comparing with those of SLN prepared by conventional aqueoethod. The SLN prepared by the novel method displayed smaller particles size and higher dus solvent diffusion mrug entrapment efficiency than those of SLN prepared by the conventional method. The drug entrapment efficiency decreased with increasing of charged amount of drug, and 15.9% of drug loading was achieved as the charged amount of drug was 20%. The in vitro drug release tests indicated that the drug release rate was faster than that of SLN prepared by the conventional method, and the drug content in SLN did not affect the in vitro drug release profile.     

Structural properties of solid lipid based colloidal drug delivery systems

For about 20 years nanoparticles based on solid lipids have been under investigation as drug carrier systems. They can be prepared from a broad variety of lipid matrix materials including glycerides, fatty acids and waxes and are stabilized by physiologically compatible surfactants. Although the matrix lipids principally retain their material properties when dispersed into the colloidal state there are various peculiarities that have to be observed when dealing with such systems. In particular, the crystallization behavior and the polymorphic transitions are altered in the nanoparticulate systems. These properties as well as the particle shape and structure may be affected by the type of surfactants used for stabilization. Also incorporated drugs can modify the structural characteristics of the nanoparticles. Interactions between the individual particles may lead to alterations of the macroscopic behavior of the dispersions, especially of their rheological properties. Such structural parameters can influence the drug carrier properties of the dispersions.     

Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables

This study aimed to prepare solid lipid nanoparticles (SLNs) of a hydrophobic drug, tretinoin, by emulsification-ultrasonication method. Solubility of tretinoin in the solid lipids was examined. Effects of process variables were investigated on particle size, polydispersity index (PI), zeta potential (ZP), drug encapsulation efficiency (EE), and drug loading (L) of the SLNs. Shape and surface morphology of the SLNs were investigated by cryogenic field emission scanning electron microscopy (cryo-FESEM). Complete encapsulation of drug in the nanoparticles was checked by cross-polarized light microscopy and differential scanning calorimetry (DSC). Crystallinity of the formulation was analyzed by DSC and powder X-ray diffraction (PXRD). In addition, drug release and stability studies were also performed. The results indicated that 10mg tretinoin was soluble in 0.45±0.07 g Precirol? ATO5 and 0.36±0.06 g Compritol? 888ATO, respectively. Process variables exhibited significant influence in producing SLNs. SLNs with <120 nm size, <0.2 PI, >I30I mV ZP, >75% EE, and ～0.8% L can be produced following the appropriate formulation conditions. Cryo-FESEM study showed spherical particles with smooth surface. Cross-polarized light microscopy study revealed that drug crystals in the external aqueous phase were absent when the SLNs were prepared at ≤0.05% drug concentration. DSC and PXRD studies indicated complete drug encapsulation within the nanoparticle matrix as amorphous form. The drug release study demonstrated sustained/prolonged drug release from the SLNs. Furthermore, tretinoin-loaded SLNs were stable for 3 months at 4°C. Hence, the developed SLNs can be used as drug carrier for sustained/prolonged drug release and/or to improve oral absorption/bioavailability.     

Large-scale self-assembly of hydrophilic gold nanoparticles at oil/water interface and their electro-oxidation for nitric oxide in solution

Mono-/bi-layer Au nanoparticle films with large areas were prepared by the assembly of Au nanoparticles in aqueous colloid at toluene/water interfaces, which can be transferred onto the hydrophilic solid surface and adhere strongly to the substrate without any binding agent. The transferred Au nanoparticle films exhibited satisfactory catalytic performance for electro-oxidizing nitric oxide (NO) in solution, and had a low detection limit (2.7 × 10⁻⁸ mol/L), a rapid response time (less than 0.5 s) and a wide linear range (5.0 × 10⁻⁸–1.0 × 10⁻⁵ mol/L) for the detection of NO in solution. UV–vis spectra, cyclic voltammetry and chronoamperometry were conducted to characterize the prepared Au nanoparticle films.     

Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells

Catanionic solid lipid nanoparticles (CASLNs), loaded with doxorubicin (Dox) and grafted with anti-epithelial growth factor receptor (EGFR) (anti-EGFR/Dox-CASLNs), were applied to suppressing propagation of malignant U87MG cells. U87MG cells were cultured with anti-EGFR/Dox-CASLNs for assessing the cell viability and EGFR expression. When the concentration of catanionic surfactants, containing hexadecyltrimethylammonium bromide and sodium anionic sodium dodecylsulfate, was 1mM, CASLNs entrapped the largest quantity of Dox. The order of cacao butter (CB) in the entrapment efficiency of Dox was 50% CB>0% CB>100% CB. In addition, the release rate of Dox and the antiproliferative effect on U87MG cells were in the following order: 100% CB>0% CB>50% CB. A high level of CB in anti-EGFR/Dox-CASLNs reduced the cytotoxicity to human brain-microvascular endothelial cells. The immunochemical staining revealed that the crosslinked anti-EGFR on the surface of Dox-CASLNs preserved a high specificity in recognizing EGFR on U87MG cells and inducing growth-inhibition effect. The innovated anti-EGFR/Dox-CASLNs can be an effective delivery system with high targeting efficacy against the growth of brain glioblastomas carcinoma.     

Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of β-carotene and α-tocopherol

UVA exposure induces DNA damage that could result in skin carcinogenesis. Antioxidants are usually employed as protective agents to avoid this problem: in particular, both β-carotene and α-tocopherol can protect the skin against UVA-induced damage. It is well known that the photochemical instability of these compounds has been a limiting factor for their applications to protect skin. In this study, stearyl ferulate-based solid lipid nanoparticles (SF-SLNs), as vehicles for β-carotene and α-tocopherol, were formulated to improve the stability of these compounds. The SF-SLNs were characterized for entrapment efficiency, size and shape together with their cytotoxicity and capability to inhibit lipid peroxidation. After treatment with a pro-oxidant and/or exposition to sunlight the antioxidants entrapped in SF-SLNs were extremely stable. The results highlighted how SF-SLNs represent a suitable vehicle for β-carotene and α-tocopherol stabilizing and protecting them from degradation. A dermatological formulation in order to prevent skin damages is, therefore, suggested.     

Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles

In order to introduce hydrophilic peptide drugs into solid lipid nanoparticles (SLN), a technique of combining hydrophobic ion pairing (HIP) and non-aqueous oil-in-oil (O/O) emulsion-evaporation was developed. Leuprolide (LR) was selected as the model drug, while sodium stearate (SA-Na) was used as the negative charged ion pairing material. The formation of leuprolide-sodium stearate (LR-SA-Na) complex was confirmed by differential scanning calorimetry (DSC). It was observed that when the molar ratio of SA-Na/LR reached 2/1, ca 88.5% LR was incorporated into the hydrophobic ion complexes with SA-Na. Compared with the conventional method of solvent diffusion in an aqueous system, the efficiency of LR drug entrapment with SLN increased from 28.0% to 74.6% by the combined technique of HIP and O/O emulsion-evaporation. In vitro drug release tests revealed that employing technique of HIP obviously reduced the burst release and slowed down the rate of drug release. At meanwhile, applying the method of non-aqueous O/O emulsion-evaporation, the longer time of drug release but relatively higher drug burst release ratio was observed in comparison with those by the solvent diffusion method in an aqueous system. The drug entrapment and release behaviors of LR-SA-Na SLN prepared by the O/O emulsion-evaporation method suggested that it could potentially be exploited as an oral delivery system for leuprolide.     

Fabrication of glucose biosensor for whole blood based on Au/hyperbranched polyester nanoparticles multilayers by antibiofouling and self-assembly technique

Acknowledging the benefits of hyperbranched polymers and their nanoparticles, herein we report the design and synthesis of sulfonic acid group functionalized hydroxyl-terminated hyperbranched polyester (H30-SO₃H) nanoparticles and their biomedical application. The H30-SO₃H nanoparticles were characterized by transmission electron microscopy (TEM), Fourier transform infrared (FTIR) spectroscopy and proton nuclear magnetic resonance spectroscopy (¹H NMR). The good hemocompatibility of H30-SO₃H nanoparticles was also investigated by coagulation tests, complement activation and platelet activation. The novel glucose biosensor was fabricated by immobilizing the positively charged Au nanoparticles, H30-SO₃H nanoparticles and glucose oxidase (GOx) onto the surface of glassy carbon electrode (GCE). It can be applied in whole blood directly, which was based on the good hemocompatibility and antibiofouling property of H30-SO₃H nanoparticles. The biosensor had good electrocatalytic activity toward glucose with a wide linear range (0.2–20 mM), a low detection limit 1.2 × 10⁻⁵ M in whole blood and good anti-interference property. The development of materials science will offer a novel platform for application to substance detection in whole blood.     

Impact of arginine-modified solid lipid nanoparticles on the membrane charge of human brain-microvascular endothelial cells

Electrokinetic and electrostatic properties of human brain-microvascular endothelial cells (HBMECs) with the uptake of l-arginine (Arg)-modified solid lipid nanoparticles (RSLNs) were investigated. The exposure of these HBMECs to radiofrequency electromagnetic field (EMF) was also considered. As compared with the original culture of HBMECs, the uptake of the biomimetic RSLNs induced smaller absolute values of electrophoretic mobility, zeta potential, Donnan potential, and fixed charge density. In addition, an increase in the coverage fraction of Arg on the external layers of the RSLNs reduced the electrical characteristics of HBMECs. An increase in the power of EMF also decreased the charge of RSLNs-incorporating HBMECs. On the contrary, softness of HBMECs was enhanced by an increased coverage fraction of Arg and an increased power of EMF. Electrophysiology of HBMECs can be efficiently mediated by the novel RSLNs and exposure to EMF through fluctuation and redistribution of the membrane charge.     

Determination of lipid content and stability in lipid nanoparticles using ultra high-performance liquid chromatography in combination with a Corona Charged Aerosol Detector

For many years, lipid nanoparticles (LNPs) have been used as delivery vehicles for various payloads (especially various oligonucleotides and mRNA), finding numerous applications in drug and vaccine development. LNP stability and bilayer fluidity are determined by the identities and the amounts of the various lipids employed in the formulation and LNP efficacy is determined in large part by the lipid composition which usually contains a cationic lipid, a PEG-lipid conjugate, cholesterol, and a zwitterionic helper phospholipid. Analytical methods developed for LNP characterization must be able to determine not only the identity and content of each individual lipid component (i.e., the parent lipids), but also the associated impurities and degradants. In this work, we describe an efficient and sensitive reversed-phase chromatographic method with charged aerosol detection (CAD) suitable for this purpose. Sample preparation diluent and mobile phase pH conditions are critical and have been optimized for the lipids of interest. This method was validated for its linearity, accuracy, precision, and specificity for lipid analysis to support process and formulation development for new drugs and vaccines.     

Preparation and self-assembly of copper nanoparticles via discharge of copper rod electrodes in a surfactant solution: a combination of physical and chemical processes

Cu nanoparticles with a mean diameter of 10-15 nm were prepared and self-assembled via discharge of bulk copper rods in a cetyltrimethylammonium bromide (CTAB)/ascorbic acid solution. Ascorbic acid was used as a protective agent to prevent the nascent Cu nanoparticles from oxidation in the solution; otherwise spindle-like Cu₂O/CuO structures, with a lateral dimension of 30-50 nm and length of up to 100 nm, were formed in pure deionized water. The surfactant CTAB had a critical influence on self-assembly of spherical Cu nanostructures (with diameter of 700 nm-1 μm). Such a low-temperature and non-vacuum method, exhibiting the characters of both physical and chemical processes, provides a versatile choice for economical preparation and assembly of various metal nanostructures.     

Dielectric and electro-optical properties of a nematic liquid crystalline material with gold nanoparticles

ABSTRACT

We have prepared the composites of a room temperature nematic liquid crystalline material namely 4-(trans-4′-n-hexylcyclohexyl) isothiocyanatobenzoate (6CHBT) and gold nanoparticles (GNPs). Thermodynamic, electro-optical and dielectric properties have been investigated. Effect of dispersion of GNPs on various electro-optical and display parameters of host liquid crystalline material have been studied. Physical parameters such as threshold voltage, dielectric anisotropy and splay elastic constant have altered for composite systems. Due to the dispersion of GNPs, nematic to isotropic transition temperature is significantly increased. Relaxation frequency corresponding to flip-flop motion of the 6CHBT molecules about their short axes has increased due to the presence of GNPs.     

Preparation, optimization and thermal characterization of a novel conductive thermoset nanocomposite containing polythiophene nanoparticles using dynamic thermal analysis

Polythiophene nanoparticles as a conductive filler was prepared with average diameter of 20-35 nm and its molecular structure was confirmed by the FT-IR, TEM, XRD and UV-vis analysis. A new conductive epoxy nanocomposite was synthesized by curing of diglycidyl ether of bisphenol A/4,4′-(4,4′ Isopropylidenediphenoxy) bis (Phthalic Anhydride) involving various percentages of polythiophene nanoparticles. DSC and DMTA studies revealed that low percentage of the polythiophene nanoparticles, i.e. 1%, results in improved crosslink density as evidenced by increasing in the glass transition temperature. The addition of polythiophene nanoparticles into the epoxy matrix resulted in a significant increment in the electrical conductivity, mechanical properties, thermal stability and activation energy of thermal degradation. The advanced isoconversional method is utilized to describe the curing behavior and thermal degradation process of the neat epoxy and epoxy nanocomposite. We have utilized the Coats-Redfern and Criado methods to find the solid state thermal degradation reaction mechanism. For the nanocomposite, the mechanism was recognized to be two-dimensional diffusion (D₂) reaction and it changes to a nucleation and growth (A₄) for pure epoxy system.     

Development and validation of TLC‐densitometric method for determination of lipid A adjuvant as a bulk and in solid fat nanoemulsions

A simple, sensitive, selective and precise high‐performance thin‐layer chromatographic method was developed for determination of lipid A (MPLA) adjuvant as a bulk and in solid fat nanoemulsions. Chromatographic separations were performed on thin‐layer chromatography aluminum plates precoated with silica gel 60 F‐254 as stationary phase and chloroform–methanol–ethyl acetate solution (10:2:4, v/v/v) as mobile phase. With this solvent system, compact spots for MPLA at R_f value 0.80 ± 0.02 were obtained. Densitometric analysis of MPLA was carried out in absorbance mode at 357 nm. Linear regression analysis for the calibration plots showed good linear relationship with r = 0.9996 in the concentration range of 20–100 ng/spot. The mean values (±SD) of slope and intercept were found to be 7.355 ± 0.006 and 109.52 ± 0.170, respectively. Limits of detection (LOD) and quantitation (LOQ) were observed at 3.096 and 9.382 ng/spot, respectively.The method was validated for precision, accuracy, robustness and recovery as per the International Conference on Harmonization guidelines. Statistical analysis proved that the developed method for quantification of MPLA as a bulk and in solid fat nanoemulsions is reproducible, selective and economical. This method could be applied for quantitative assay of MPLA in lipid‐based vaccine formulations. Copyright © 2015 John Wiley & Sons, Ltd.